About FDA
Percentage of trilateral meetings conducted in the quarter
Dictionary: CVM’s regular meeting with key regulatory counterparts in Canada and the European Union and with other significant regulatory partners assure the close and timely communication necessary to deal effectively with emerging problems. Each meeting is set up with a specific agenda designed to share subjects and issues of mutual interest and concern. Strengthening public health and animal health regulatory infrastructures between our most significant trading partners helps to assure the quality, safety, and efficacy of products from those countries.
Information is current as of February 28, 2013.
Fiscal Year - 2013
| Time | Target | Percent |
|---|---|---|
| Oct - Dec 2012 | 95 | 100 |
| Jan - Mar 2013 | 95 | TBD |
| Apr - Jun 2013 | 95 | TBD |
| Jul - Sept 2013 | 95 | TBD |
FY 2013 YTD: 100
Number of CVM trilateral meetings held in the quarter
Fiscal Year - 2013
| Time | Target | Number |
|---|---|---|
| Oct - Dec 2012 | N/A | 4 |
| Jan - Mar 2013 | N/A | TBD |
| Apr - Jun 2013 | N/A | TBD |
| Jul - Sept 2013 | N/A | TBD |
FY 2013 YTD:4
Total number of scheduled CVM trilateral meetings in the quarter
Fiscal Year - 2013
| Time | Target | Number |
|---|---|---|
| Oct - Dec 2012 | N/A | 4 |
| Jan - Mar 2013 | N/A | TBD |
| Apr - Jun 2013 | N/A | TBD |
| Jul - Sept 2013 | N/A | TBD |
FY 2013 YTD:4
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
